Progress In Cancer Immunotherapy by Shuren ZhangProgress In Cancer Immunotherapy by Shuren Zhang

Progress In Cancer Immunotherapy

byShuren Zhang

Hardcover | June 6, 2016

Pricing and Purchase Info


Earn 1,380 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.

Dr. Shuren Zhang is a professor and the director of Department of Immunology, Cancer Institute & Hospitalï¼Chinese Academy of Medical Sciences & Peking Union Medical College. He is the vice chairman of the society of Cancer Biotherapy of Chinese Anti-Cancer Association. His research focuses on tumor immunology and cancer immunotherapy,...
Title:Progress In Cancer ImmunotherapyFormat:HardcoverDimensions:283 pages, 23.5 × 15.5 × 0.03 inPublished:June 6, 2016Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401775532

ISBN - 13:9789401775533

Look for similar items by category:


Table of Contents

Antibody therapies in cancer.- Biological Response Modifier in Cancer Immunotherapy.- Progress and Development of Therapeutic Cancer Vaccines.- Adoptive Cellular Therapy (ACT) for Cancer Treatment.- Oncolytic Immunotherapy for Treatment of Cancer .